PBS price comparisons too simplistic: Medicines Australia

Claims that the Australian Government is paying more for PBS medicines compared to other countries are a “simplistic comparison” and do not account for ongoing savings achieved by simplified price disclosure, according to Medicines Australia.

In a statement, the organisation took aim at comments from health economist Dr Philip Clarke, who has said the Government is overpaying $400 million a year on PBS-listed medicines.

Dr Clarke’s comments were featured in a series of articles published by News Limited earlier this week, where he